Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07550127

Peri-implantitis Management: Surgical and Maintenance Outcomes

Led by University of Pittsburgh · Updated on 2026-05-01

44

Participants Needed

1

Research Sites

175 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn how two standard surgical treatments for peri-implantitis affect inflammation around dental implants. Participants will be randomly assigned to receive resective surgery with implantoplasty or resective surgery with mechanical debridement only. Participants will provide blood samples before surgery, about 48 hours and 2 weeks after surgery. Participants will also provide a small gum tissue sample and fluid from around the implant at baseline and about 3 months after surgery. Participants will be followed in a maintenance program for up to 5 years.

CONDITIONS

Official Title

Peri-implantitis Management: Surgical and Maintenance Outcomes

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 or older
  • In good general health, classified as ASA Physical Status I or II
  • Diagnosed with peri-implantitis requiring resective surgical treatment, defined by bleeding on probing around implants
  • Probing pocket depths greater than 6 mm
  • Implants in function for over 1 year with progressive bone loss exceeding 3 mm
  • Initial diagnosis confirmed by panoramic radiographs, cone-beam CT, and clinical exam
  • For maintenance phase: probing depth of 5 mm or less
  • Bleeding on probing at 1 point or less
  • No suppuration present
  • No progressive bone loss compared to pre-treatment levels
Not Eligible

You will not qualify if you...

  • Autoimmune or systemic inflammatory diseases like lupus or rheumatoid arthritis
  • Chronic use of systemic corticosteroids or immunosuppressants in the past 3 months
  • Uncontrolled diabetes with HbA1c greater than 7.5%
  • Active infection or antibiotic use within 30 days before baseline
  • Pregnancy or breastfeeding
  • Unable to undergo venipuncture or tolerate soft tissue biopsy
  • Unable to attend 3-month follow-up or comply with study protocol
  • History of cancer requiring systemic therapy within past 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Pittsburgh School of Dental Medicine

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

Loading map...

Research Team

A

Andrea Ravida, DDS, MS, PhD

CONTACT

C

Carla Sanchez, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here